MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain

An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex

Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · see citing works

Argonaute HITS-CLIP decodes microRNA–mRNA interaction maps

Chi, S. W., Zang, J. B., Mele, A., & Darnell, R. B. (2009) · Nature · doi:10.1038/nature08170 · Cited by 1,791 · see citing works

The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS

Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248 · see citing works

Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy

Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937 · see citing works

Non-ATG–initiated translation directed by microsatellite expansions

Zu, T., Gibbens, B. B., Doty, N. S., Gomes-Pereira, M., Huguet-Lachon, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 904 · see citing works

RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia

Zu, T., Liu, Y., Báñez-Coronel, M., Reid, T. S., Pletniková, O., Lewis, J. M., Miller, T. M., Harms, M. B., Falchook, A. E., Subramony, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315438110 · Cited by 748 · see citing works

A Muscleblind Knockout Model for Myotonic Dystrophy

Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743 · see citing works

<i>C9orf72</i> repeat expansions cause neurodegeneration in <i>Drosophila</i> through arginine-rich proteins

Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O. C., Pietrzyk, J., et al. (2014) · Science · doi:10.1126/science.1256800 · Cited by 740 · see citing works

Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells

Kwon, I., Xiang, S., Kato, M., Wu, L. C., Theodoropoulos, P., Wang, T., Kim, J., Yun, J., Xie, Y., & McKnight, S. L. (2014) · Science · doi:10.1126/science.1254917 · Cited by 648 · see citing works

A quantitative atlas of polyadenylation in five mammalsPreprint

Derti, A., Garrett-Engele, P. W., MacIsaac, K. D., Stevens, R. C., Sriram, S., Chen, R., Rohl, C. A., Johnson, J. M., & Babak, T. (2012) · Genome Research · doi:10.1101/gr.132563.111 · Cited by 642 · see citing works

Variable tandem repeats accelerate evolution of coding and regulatory sequences

Gemayel, R., Vinces, M. D., Legendre, M., & Verstrepen, K. J. (2010) · Annual Review of Genetics · doi:10.1146/annurev-genet-072610-155046 · Cited by 633 · see citing works

Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons

Jiang, H. N., Mankodi, A. K., Swanson, M. S., Moxley, R. T., & Thornton, C. A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh327 · Cited by 528 · see citing works

Antisense Proline-Arginine RAN Dipeptides Linked to C9ORF72-ALS/FTD Form Toxic Nuclear Aggregates that Initiate In Vitro and In Vivo Neuronal Death

Wen, X., Tan, W., Westergard, T., Krishnamurthy, K., Markandaiah, S. S., Shi, Y., Lin, S., Shneider, N. A., Monaghan, J., Pandey, U. B., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.12.010 · Cited by 513 · see citing works

Muscleblind proteins regulate alternative splicing

Ho, T. H., Charlet‐Berguerand, N., Poulos, M. G., Singh, G., Swanson, M. S., & Cooper, T. A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600300 · Cited by 494 · see citing works

Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins

Wang, E. T., Cody, N. A. L., Jog, S., Biancolella, M., Wang, T. T., Treacy, D. J., Luo, S., Schroth, G. P., Housman, D. E., Reddy, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.041 · Cited by 490 · see citing works

Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic

Lee, Y., Chen, H.-J., Peres, J., Gómez-Deza, J., Attig, J., Štalekar, M., Troakes, C., Nishimura, A. L., Scotter, E. L., Vance, C. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.049 · Cited by 487 · see citing works

Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells

Fardaei, M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.7.805 · Cited by 464 · see citing works

Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy

Kanadia, R., Shin, J., Yuan, Y., Beattie, S. G., Wheeler, T. M., Thornton, C. A., & Swanson, M. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604970103 · Cited by 372 · see citing works

hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations

Mori, K., Lammich, S., Mackenzie, I. R., Forné, I., Zilow, S., Kretzschmar, H. A., Edbauer, D., Janssens, J., Kleinberger, G., Cruts, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1088-7 · Cited by 339 · see citing works

Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy

Charizanis, K., Lee, K.-Y., Batra, R., Goodwin, M., Zhang, C., Yuan, Y., Shiue, L., Cline, M., Scotti, M. M., Xia, G., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.029 · Cited by 324 · see citing works

The Disease-associated r(GGGGCC) Repeat from the C9orf72 Gene Forms Tract Length-dependent Uni- and Multimolecular RNA G-quadruplex Structures

Reddy, K., Zamiri, B., Stanley, S. Y., Macgregor, R. B., & Pearson, C. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.452532 · Cited by 314 · see citing works

Loss of MBNL Leads to Disruption of Developmentally Regulated Alternative Polyadenylation in RNA-Mediated Disease

Batra, R., Charizanis, K., Manchanda, M., Mohan, A., Li, M., Finn, D. J., Goodwin, M., Zhang, C., Sobczak, K., Thornton, C. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.027 · Cited by 292 · see citing works

Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1

Sergeant, N. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2143 · Cited by 281 · see citing works

Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy

Rau, F., Freyermuth, F., Fugier, C., Villemin, J.-P., Fischer, M., Jost, B., Dembélé, D., Gourdon, G., Nicole, A., Duboc, D., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2067 · Cited by 280 · see citing works

The Unstable Repeats—Three Evolving Faces of Neurological Disease

Nelson, D. L., Orr, H. T., & Warren, S. T. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.022 · Cited by 200 · see citing works

Compound loss of muscleblind‐like function in myotonic dystrophy

Lee, K., Li, M., Manchanda, M., Batra, R., Charizanis, K., Mohan, A., Warren, S., Chamberlain, C. M., Finn, D., Hong, H., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303275 · Cited by 190 · see citing works

Profiling Murine Tau with 0N, 1N and 2N Isoform-Specific Antibodies in Brain and Peripheral Organs Reveals Distinct Subcellular Localization, with the 1N Isoform Being Enriched in the Nucleus

Liu, C., & Götz, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084849 · Cited by 155 · see citing works

CLIP: Crosslinking and ImmunoPrecipitation of In Vivo RNA Targets of RNA-Binding Proteins

Jensen, K. B., & Darnell, R. B. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-475-3_6 · Cited by 143 · see citing works

OLego: fast and sensitive mapping of spliced mRNA-Seq reads using small seeds

Wu, J., Anczuków, O., Krainer, A. R., Zhang, M. Q., & Zhang, C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt216 · Cited by 123 · see citing works

The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing

Ravel‐Chapuis, A., Bélanger, G., Yadava, R. S., Mahadevan, M. S., DesGroseillers, L., Côté, J., & Jasmin, B. J. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201108113 · Cited by 116 · see citing works

Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders

Cleary, J. D., & Ranum, L. P. W. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.03.002 · Cited by 111 · see citing works

Muscleblind-Like 1 Knockout Mice Reveal Novel Splicing Defects in the Myotonic Dystrophy Brain

Suenaga, K., Lee, K., Nakamori, M., Tatsumi, Y., Takahashi, M. P., Fujimura, H., Jinnai, K., Yoshikawa, H., Du, H., Ares, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033218 · Cited by 96 · see citing works

HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence

Kim, D.-H. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki698 · Cited by 88 · see citing works

RNA-binding proteins in microsatellite expansion disorders: Mediators of RNA toxicity

Echeverria, G. V., & Cooper, T. A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.030 · Cited by 88 · see citing works

Tau alternative splicing in familial and sporadic tauopathies

Niblock, M., & Gallo, J. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120091 · Cited by 87 · see citing works

Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins

Kino, Y., Washizu, C., Kurosawa, M., Oma, Y., Hattori, N., Ishiura, S., & Nukina, N. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu492 · Cited by 80 · see citing works

New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats

Laurent, F.-X., Sureau, A., Klein, A. F., Trouslard, F., Gasnier, E., Furling, D., & Marie, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1228 · Cited by 73 · see citing works

Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice

Poulos, M. G., Batra, R., Li, M., Yuan, Y., Zhang, C., Darnell, R. B., & Swanson, M. S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt209 · Cited by 69 · see citing works

Prediction of clustered RNA-binding protein motif sites in the mammalian genome

Zhang, C., Lee, K., Swanson, M. S., & Darnell, R. B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt421 · Cited by 65 · see citing works

dCLIP: a computational approach for comparative CLIP-seq analyses

Wang, T., Xie, Y., & Xiao, G. (2014) · Genome biology · doi:10.1186/gb-2014-15-1-r11 · Cited by 63 · see citing works

Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats

Dhaenens, C., Schraen‐Maschke, S., Tran, H., Vingtdeux, V., Ghanem, D., Leroy, O., Delplanque, J., Vanbrussel, E., Delacourte, A., Vermersch, P., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.020 · Cited by 59 · see citing works

RNA–protein interactions in unstable microsatellite diseases

Mohan, A., Goodwin, M., & Swanson, M. S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.039 · Cited by 55 · see citing works

DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1

Pettersson, O. J., Aagaard, L., Andrējeva, D., Thomsen, R., Jensen, T. G., & Damgaard, C. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku352 · Cited by 49 · see citing works

RNA-Binding Protein Misregulation in Microsatellite Expansion Disorders

Goodwin, M., & Swanson, M. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_10 · Cited by 33 · see citing works

Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2

Carpentier, C., Ghanem, D., Fernández-Gómez, F.-J., Jumeau, F., Philippe, J.-V., Freyermuth, F., Labudeck, A., Eddarkaoui, S., Dhaenens, C., Holt, I., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.004 · Cited by 29 · see citing works

MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1

Huin, V., Vasseur, F., Schraen‐Maschke, S., Dhaenens, C., Devos, P., Dupont, K., Sergeant, N., Buée, L., Lacour, A., Radvanyi, H., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6740-y · Cited by 17 · see citing works

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting

Fernández-Gómez, F.-J., Jumeau, F., Derisbourg, M. J., Burnouf, S., Tran, H., Eddarkaoui, S., Obriot, H., Dutoit, V., Deramecourt, V., Mitchell, V. A., et al. (2014) · Journal of Visualized Experiments · doi:10.3791/51339 · Cited by 9 · see citing works

Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism

Yang, Y., Hsu, P. J., Chen, Y.-S., & Yang, Y. (2018) · Cell Research · doi:10.1038/s41422-018-0040-8 · Cited by 1,683 · see citing works

Alternative splicing as a regulator of development and tissue identity

Baralle, F. E., & Giudice, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.27 · Cited by 1,333 · see citing works

The neurogenetics of alternative splicing

Vuong, C. K., Black, D. L., & Zheng, S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.27 · Cited by 340 · see citing works

Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions

Nussbacher, J. K., Tabet, R., Yeo, G. W.-M., & Lagier‐Tourenne, C. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.014 · Cited by 264 · see citing works

Distal Alternative Last Exons Localize mRNAs to Neural Projections

Taliaferro, J. M., Vidaki, M., Oliveira, R., Olson, S., Zhan, L., Saxena, T., Wang, E. T., Graveley, B. R., Gertler, F. B., Swanson, M. S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.020 · Cited by 240 · see citing works

Defective control of pre–messenger RNA splicing in human disease

Chabot, B., & Shkreta, L. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201510032 · Cited by 209 · see citing works

Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy

Freyermuth, F., Rau, F., Kokunai, Y., Linke, T., Sellier, C., Nakamori, M., Kino, Y., Arandel, L., Jollet, A., Thibault-Carpentier, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms11067 · Cited by 206 · see citing works

Alternative splicing in neurodegenerative disease and the promise of RNA therapies

Nikom, D., & Zheng, S. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00717-6 · Cited by 189 · see citing works

Core Clinical Phenotypes in Myotonic Dystrophies

Wenninger, S., Montagnese, F., & Schoser, B. G. H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00303 · Cited by 167 · see citing works

Roles for RNA-binding proteins in development and disease

Brinegar, A. E., & Cooper, T. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.050 · Cited by 151 · see citing works

RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2

Zu, T., Cleary, J. D., Liu, Y., Báñez-Coronel, M., Bubenik, J. L., Ayhan, F., Ashizawa, T., Xia, G., Clark, H. B., Yachnis, A. T., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.08.039 · Cited by 141 · see citing works

RNA metabolism in neurodegenerative disease

Liu, E. Y., Cali, C. P., & Lee, E. B. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028613 · Cited by 137 · see citing works

An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I

López‐Martínez, A., Soblechero‐Martín, P., Ovejero, L. D. L. P., Nogales‐Gadea, G., & Arechavala‐Gomeza, V. (2020) · Genes · doi:10.3390/genes11091109 · Cited by 132 · see citing works

Transcriptome alterations in myotonic dystrophy skeletal muscle and heart

Wang, E. T., Treacy, D. J., Eichinger, K. J., Struck, A. J., Estabrook, J., Olafson, H. R., Wang, T. T., Bhatt, K. S., Westbrook, T., Sedehizadeh, S., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy432 · Cited by 122 · see citing works

Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy

Sznajder, Ł. J., & Swanson, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133365 · Cited by 103 · see citing works

Dysregulation of mRNA Localization and Translation in Genetic Disease

Wang, E. T., Taliaferro, J. M., Lee, J.-A., Sudhakaran, I. P., Rossoll, W., Groß, C., Moss, K. R., & Bassell, G. J. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2352-16.2016 · Cited by 115 · see citing works

Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophyPreprint

Thomas, J. D., Sznajder, Ł. J., Bardhi, O., Aslam, F. N., Anastasiadis, Z. P., Scotti, M. M., Nishino, I., Nakamori, M., Wang, E. T., & Swanson, M. S. (2017) · Genes & Development · doi:10.1101/gad.300590.117 · Cited by 94 · see citing works

Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS

Gourdon, G., & Meola, G. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00101 · Cited by 93 · see citing works

Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome

Glineburg, M. R., Todd, P. K., Charlet‐Berguerand, N., & Sellier, C. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.006 · Cited by 90 · see citing works

miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models

Cerro-Herreros, E., Sabater-Arcis, M., Fernández‐Costa, J. M., Moreno, N., Pérez‐Alonso, M., Llamusí, B., & Artero, R. D. (2018) · Nature Communications · doi:10.1038/s41467-018-04892-4 · Cited by 89 · see citing works

Widespread Accumulation of Ribosome-Associated Isolated 3′ UTRs in Neuronal Cell Populations of the Aging Brain

Sudmant, P. H., Lee, H., Dominguez, D., Heiman, M., & Burge, C. B. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.094 · Cited by 83 · see citing works

Trinucleotide Repeat Expansion in the Transcription Factor 4 ( TCF4 ) Gene Leads to Widespread mRNA Splicing Changes in Fuchs' Endothelial Corneal Dystrophy

Wieben, E. D., Aleff, R. A., Tang, X., Butz, M. L., Kalari, K. R., Highsmith, E. W., Jen, J., Vasmatzis, G., Patel, S. V., Maguire, L. J., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20900 · Cited by 81 · see citing works

rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences

Sellier, C., Cerro-Herreros, E., Blatter, M., Freyermuth, F., Gaucherot, A., Ruffenach, F., Sarkar, P. S., Puymirat, J., Udd, B., Day, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04370-x · Cited by 74 · see citing works

Transcriptome alterations in myotonic dystrophy frontal cortex

Otero, B. A., Poukalov, K., Hildebrandt, R. P., Thornton, C. A., Jinnai, K., Fujimura, H., Kimura, T., Hagerman, K. A., Sampson, J. B., Day, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108634 · Cited by 64 · see citing works

Ubiquitination of MBNL1 Is Required for Its Cytoplasmic Localization and Function in Promoting Neurite Outgrowth

Wang, P.-Y., Chang, K., Lin, Y.-M., Kuo, T., & Wang, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.025 · Cited by 51 · see citing works

HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy

Li, M., Zhuang, Y., Batra, R., Thomas, J. D., Mao, L., Nutter, C. A., Scotti, M. M., Carter, H. A., Wang, Z. J., Huang, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907297117 · Cited by 51 · see citing works

Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy

Wojciechowska, M., Sobczak, K., Kozłowski, P., Sedehizadeh, S., Wojtkowiak-Szlachcic, A., Czubak, K., Márkus, R., Łusakowska, A., Kamińska, A., & Brook, J. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-24156-x · Cited by 50 · see citing works

Dynamic characterization and interpretation for protein-RNA interactions across diverse cellular conditions using HDRNet

Zhu, H., Yang, Y., Wang, Y., Wang, F., Huang, Y., Chang, Y., Wong, K., & Li, X. (2023) · Nature Communications · doi:10.1038/s41467-023-42547-1 · Cited by 48 · see citing works

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

Benichou, S. A., Jauvin, D., Serres‐Bérard, T. D., Pierre, M., Ling, K., Bennett, C. F., Rigo, F., Gourdon, G., Chahine, M., & Puymirat, J. (2022) · Gene Therapy · doi:10.1038/s41434-022-00316-7 · Cited by 48 · see citing works

Downregulation of the Glial GLT1 Glutamate Transporter and Purkinje Cell Dysfunction in a Mouse Model of Myotonic Dystrophy

Sicot, G., Servais, L., Dincã, D. M., Leroy, A., Prigogine, C., Medja, F., Braz, S. O., Huguet-Lachon, A., Chhuon, C., Nicole, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.006 · Cited by 46 · see citing works

Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila

Cerro-Herreros, E., Fernández‐Costa, J. M., Sabater-Arcis, M., Llamusí, B., & Artero, R. D. (2016) · Scientific Reports · doi:10.1038/srep36230 · Cited by 45 · see citing works

Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy

Bráz, S., Acquaire, J., Gourdon, G., & Gomes-Pereira, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00519 · Cited by 45 · see citing works

Native functions of short tandem repeats

Wright, S. E., & Todd, P. K. (2023) · eLife · doi:10.7554/elife.84043 · Cited by 43 · see citing works

Myotonic Dystrophy and Developmental Regulation of RNA Processing

Thomas, J. D., Oliveira, R., Sznajder, Ł. J., & Swanson, M. S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170002 · Cited by 47 · see citing works

TGC repeat expansion in the TCF4 gene increases the risk of Fuchs’ endothelial corneal dystrophy in Australian cases

Kuot, A., Hewitt, A. W., Snibson, G. R., Souzeau, E., Mills, R. A., Craig, J. E., Burdon, K. P., & Sharma, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183719 · Cited by 40 · see citing works

A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I

Zhang, F., Bodycombe, N. E., Haskell, K., Sun, Y., Wang, E. T., Morris, C. A., Jones, L. H., Wood, L. D., & Pletcher, M. T. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx190 · Cited by 40 · see citing works

Bioengineered in vitro 3D model of myotonic dystrophy type 1 human skeletal muscle

Fernández‐Garibay, X., Ortega, M. A., Cerro-Herreros, E., Comelles, J., Martínez, E., Artero, R. D., Fernández‐Costa, J. M., & Ramón‐Azcón, J. (2021) · Biofabrication · doi:10.1088/1758-5090/abf6ae · Cited by 38 · see citing works

Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy

Wang, P.-Y., Lin, Y.-M., Wang, L., Kuo, T., Cheng, S., & Wang, G. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx115 · Cited by 37 · see citing works

Sleep disorders in myotonic dystrophies

Subramony, S. H., Wymer, J. P., Pinto, B. S., & Wang, E. T. (2020) · Muscle & Nerve · doi:10.1002/mus.26866 · Cited by 35 · see citing works

CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during humanin vitromyogenesis

Mérien, A., Tahraoui‐Bories, J., Cailleret, M., Dupont, J.-B., Leteur, C., Polentes, J., Carteron, A., Polvèche, H., Concordet, J., Pinset, C., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab218 · Cited by 31 · see citing works

Deprivation of Muscleblind-Like Proteins Causes Deficits in Cortical Neuron Distribution and Morphological Changes in Dendritic Spines and Postsynaptic Densities

Lee, K., Chang, H., Seah, C., & Lee, L. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00075 · Cited by 30 · see citing works

Suppression of premature transcription termination leads to reduced mRNA isoform diversity and neurodegeneration

LaForce, G. R., Farr, J. S., Liu, J., Akesson, C., Gümüş, E., Pinkard, O. W., Miranda, H. C., Johnson, K., Sweet, T. J., Ji, P., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.01.018 · Cited by 29 · see citing works

Biology of RNA Surveillance in Development and Disease

Laffleur, B., & Basu, U. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.01.004 · Cited by 29 · see citing works

Targeting Myotonic Dystrophy Type 1 with Metformin

García-Puga, M., Saenz‐Antoñanzas, A., Matheu, A., & de Munaín, A. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052901 · Cited by 27 · see citing works

MECP2-related pathways are dysregulated in a cortical organoid model of myotonic dystrophy

Morelli, K. H., Jin, W., Sathe, S., Madrigal, A. A., Jones, K. L., Schwartz, J. L., Bridges, T., Mueller, J. R., Shankar, A., Chaim, I. A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn2375 · Cited by 26 · see citing works

Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1

Winkler, N. S., Milone, M., Martinez‐Thompson, J. M., Raja, H., Aleff, R. A., Patel, S. V., Fautsch, M. P., Wieben, E. D., & Baratz, K. H. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23160 · Cited by 26 · see citing works

Conserved functions of RNA-binding proteins in muscle

Nikonova, E. V., Kao, S.-Y., Ravichandran, K., Wittner, A., & Spletter, M. L. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.02.008 · Cited by 23 · see citing works

Abnormal Cortical Thickness Is Associated With Deficits in Social Cognition in Patients With Myotonic Dystrophy Type 1

Serra, L., Bianchi, G., Bruschini, M., Giulietti, G., Domenico, C. D., Bonarota, S., Petrucci, A., Silvestri, G., Perna, A., Meola, G., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00113 · Cited by 25 · see citing works

Neurodegenerative diseases and cancer: sharing common mechanisms in complex interactions

Rojas, N. G., Cesarini, M., Etcheverry, J. L., Prat, G. A. D., Arciuch, V. G. A., & Gatto, E. M. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.01.3 · Cited by 25 · see citing works

Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1

Benichou, S. A., Jauvin, D., Serres‐Bérard, T. D., Bennett, F., Rigo, F., Gourdon, G., Boutjdir, M., Chahine, M., & Puymirat, J. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.069 · Cited by 26 · see citing works

(CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage

André, L. M., van Cruchten, R. T. P., Willemse, M. P., & Wansink, D. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217317 · Cited by 24 · see citing works

Block or degrade? Balancing on- and off-target effects of antisense strategies against transcripts with expanded triplet repeats in DM1

Boujnouni, N. E., van der Bent, M. L., Willemse, M. P., Hoen, P. A. C. ’., Brock, R. E., & Wansink, D. G. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.010 · Cited by 24 · see citing works

Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer

Murmann, A. E., Yu, J., Opal, P., & Peter, M. E. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.08.004 · Cited by 25 · see citing works

Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington’s disease models

Mason, M. A., Gomez-Paredes, C., Sathasivam, K., Neueder, A., Papadopoulou, A. S., & Bates, G. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-71111-w · Cited by 24 · see citing works

A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1

Zhang, N., Bewick, B., Xia, G., Furling, D., & Ashizawa, T. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.594576 · Cited by 24 · see citing works

Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy

Lee, K., Seah, C., Li, C. L., Chen, Y.-F., Chen, C.-Y., Wu, C.-I., Liao, P.-C., Shyu, Y., Olafson, H. R., McKee, K., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac108 · Cited by 23 · see citing works

Dynamic landscape of alternative polyadenylation during retinal development

Hu, W., Li, S., Park, J. Y., Boppana, S., Ni, T., Li, M., Zhu, J., Tian, B., Xie, Z., & Xiang, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2429-1 · Cited by 22 · see citing works

Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy

Serres‐Bérard, T. D., Pierre, M., Chahine, M., & Puymirat, J. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105532 · Cited by 21 · see citing works

Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives

Rahm, L., Hale, M. A., Raaijmakers, R. H. L., Quiñones, A. M., Patki, T., Johnson, N. E., van Bokhoven, H., & Mul, K. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01139-x · Cited by 21 · see citing works

Integrative Cell Type-Specific Multi-Omics Approaches Reveal Impaired Programs of Glial Cell Differentiation in Mouse Culture Models of DM1

González‐Barriga, A., Lallemant, L., Dincã, D. M., Bráz, S., Polvèche, H., Magneron, P., Pionneau, C., Huguet-Lachon, A., Claude, J., Chhuon, C., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662035 · Cited by 21 · see citing works

Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1

Liu, J., Guo, Z., Yan, X., Yang, Y., & Huang, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.755392 · Cited by 21 · see citing works

Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion

Lee, Y.-H., Jhuang, Y., Chen, Y., Jeng, Y., & Yuan, R. (2016) · Oncotarget · doi:10.18632/oncotarget.11577 · Cited by 21 · see citing works

Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes

Cerro-Herreros, E., Chakraborty, M., Pérez‐Alonso, M., Artero, R. D., & Llamusí, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-02829-3 · Cited by 20 · see citing works

Regulation of alternative splicing and polyadenylation in neurons

Lee, S., Aubee, J. I., & Lai, E. C. (2023) · Life Science Alliance · doi:10.26508/lsa.202302000 · Cited by 21 · see citing works

Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis

Campione, E., Botta, A., Prete, M. D., Rastelli, E., Gibellini, M., Petrucci, A., Bernardini, S., Novelli, G., Bianchi, L., Orlandi, A., et al. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.11.004 · Cited by 19 · see citing works

Dementia Therapy Targeting Tau

Buée, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_30 · Cited by 18 · see citing works

Autism-related traits in myotonic dystrophy type 1 model mice are due to MBNL sequestration and RNA mis-splicing of autism-risk genes

Sznajder, Ł. J., Khan, M., Ciesiołka, A., Tadross, M., Nutter, C. A., Taylor, K., Pearson, C. E., Lewis, M. H., Hines, R. M., Swanson, M. S., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01943-0 · Cited by 17 · see citing works

Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2* Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla

Ates, S., Deistung, A., Schneider, R., Prehn, C., Lukas, C., Reichenbach, J. R., Schneider‐Gold, C., & Bellenberg, B. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01320 · Cited by 17 · see citing works

Optical Mapping Approaches on Muscleblind‐Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy

Chou, C., Chang, P., Wei, Y., & Lee, K. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005191 · Cited by 16 · see citing works

Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1

Nutter, C. A., Kidd, B. M., Carter, H. A., Hamel, J., Mackie, P. M., Kumbkarni, N., Davenport, M. L., Tuyn, D. M., Gopinath, A., Creigh, P. D., et al. (2023) · Brain · doi:10.1093/brain/awad148 · Cited by 15 · see citing works

Mbnl1 and Mbnl2 regulate brain structural integrity in mice

Maria, N. S. S., Zhou, C., Lee, S. J., Valiulahi, P., Li, X., Choi, J., Liu, X., Jacobs, R. E., Comai, L., & Reddy, S. (2021) · Communications Biology · doi:10.1038/s42003-021-02845-0 · Cited by 15 · see citing works

Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration

Wang, L., Lin, C., Lin, Y.-M., Buée, L., Sergeant, N., Blum, D. L., Chern, Y., & Wang, G. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2006-21.2022 · Cited by 16 · see citing works

Myotonic Dystrophy: an RNA Toxic Gain of Function Tauopathy?

Fernández-Gómez, F.-J., Tran, H., Dhaenens, C., Caillet‐Boudin, M., Schraen‐Maschke, S., Blum, D. L., Sablonnière, B., Buée‐Scherrer, V., Buée, L., & Sergeant, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_17 · Cited by 15 · see citing works

Functions of the Muscleblind-like protein family and their role in disease

Zhou, H., Xu, J., & Pan, L. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02102-5 · Cited by 14 · see citing works

A comprehensive atlas of fetal splicing patterns in the brain of adult myotonic dystrophy type 1 patients

Degener, M. J. F., van Cruchten, R. T. P., Otero, B. A., Wang, E. T., Wansink, D. G., & Hoen, P. A. C. ’. (2022) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqac016 · Cited by 12 · see citing works

MBNL‐dependent impaired development within the neuromuscular system in myotonic dystrophy type 1

Tahraoui‐Bories, J., Mérien, A., González‐Barriga, A., Lainé, J., Leteur, C., Polvèche, H., Carteron, A., de Lamotte, J. D., Nicoleau, C., Polentes, J., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12876 · Cited by 14 · see citing works

Protective effects of mirtazapine in mice lacking the Mbnl2 gene in forebrain glutamatergic neurons: Relevance for myotonic dystrophy 1

Ramon‐Duaso, C., Rodríguez-Morató, J., Selma-Soriano, E., Fernández-Avilés, C., Artero, R. D., de la Torre, R., Pozo, Ó. J., & Robledo, P. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108030 · Cited by 14 · see citing works

Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients

Nishi, M., Kimura, T., Igeta, M., Furuta, M., Suenaga, K., Matsumura, T., Fujimura, H., Jinnai, K., & Yoshikawa, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0224912 · Cited by 13 · see citing works

Association of prenatal acetaminophen use and acetaminophen metabolites with DNA methylation of newborns: analysis of two consecutive generations of the Isle of Wight birth cohort

Eslamimehr, S., Jones, A. D., Anthony, T. M., Arshad, S. H., Holloway, J. W., Ewart, S., Luo, R., Mukherjee, N., Rahimabad, P. K., Chen, S., et al. (2022) · Current Zoology · doi:10.1093/eep/dvac002 · Cited by 13 · see citing works

The Splicing of the Mitochondrial Calcium Uniporter Genuine Activator MICU1 Is Driven by RBFOX2 Splicing Factor during Myogenic Differentiation

Reane, D. V., Cerqua, C., Sacconi, S., Salviati, L., Trevisson, E., & Raffaello, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052517 · Cited by 12 · see citing works

Myotonic Dystrophy and Developmental Regulation of RNA Processing

Thomas, J. D., Oliveira, R., Sznajder, Ł. J., & Swanson, M. S. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00015.x · Cited by 13 · see citing works

Control of CNS Functions by RNA-Binding Proteins in Neurological Diseases

Zhou, Y., Dong, F., & Mao, Y. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0140-7 · Cited by 13 · see citing works

Cerebral involvement and related aspects in myotonic dystrophy type 2

Perić, S., Rakočević-Stojanović, V., & Meola, G. (2021) · Neuromuscular Disorders · doi:10.1016/j.nmd.2021.06.002 · Cited by 13 · see citing works

Muscleblind‐like 2 knockout shifts adducin 1 isoform expression and alters dendritic spine dynamics of cortical neurons during brain development

Huang, C., Lee, K., Lin, P., Nian, F., Cheng, H., Chang, C., Liao, C.-Y., Su, Y., Seah, C., Li, C. L., et al. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12890 · Cited by 12 · see citing works

Lineage-specific splicing regulation of MAPT gene in the primate brain

Recinos, Y., Bao, S., Wang, X., Phillips, B. L., Yeh, Y.-T., Weyn‐Vanhentenryck, S. M., Swanson, M. S., & Zhang, C. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100563 · Cited by 12 · see citing works

DM1 Transgenic Mice Exhibit Abnormal Neurotransmitter Homeostasis and Synaptic Plasticity in Association with RNA Foci and Mis-Splicing in the Hippocampus

Potier, B., Lallemant, L., Parrot, S., Huguet-Lachon, A., Gourdon, G., Dutar, P., & Gomes-Pereira, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020592 · Cited by 12 · see citing works

A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models

Ikenoshita, S., Matsuo, K., Yabuki, Y., Kawakubo, K., Asamitsu, S., Hori, K., Usuki, S., Hirose, Y., Bando, T., Araki, K., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164792 · Cited by 12 · see citing works

Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies

Espinosa-Espinosa, J., González‐Barriga, A., López, A., & Artero, R. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031441 · Cited by 11 · see citing works

Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review

Wu, Y., Wei, Q., Lin, J., Shang, H., & Ou, R. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1369332 · Cited by 10 · see citing works

Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective

Kuntawala, D. H., Vitorino, R. M. P., Cruz, A. C., Martins, F., & Rebelo, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115350 · Cited by 10 · see citing works

MBNL deficiency in motor neurons disrupts neuromuscular junction maintenance and gait coordination

Frison-Roche, C., Demier, C. M., Cottin, S., Lainé, J., Arandel, L., Halliez, M., Lemaître, M., Lornage, X., Strochlic, L., Swanson, M. S., et al. (2024) · Brain · doi:10.1093/brain/awae336 · Cited by 9 · see citing works

DM1 repeat-expanded RNAs confer RNA toxicity as individual nuclear-retained RNAs

Ouyang, J. P. T., Shukla, S., Bensalah, M., & Parker, R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115582 · Cited by 9 · see citing works

Muscleblind-1 interacts with tubulin mRNAs to regulate the microtubule cytoskeleton in C. elegans mechanosensory neurons

Puri, D., Sharma, S., Samaddar, S., Ravivarma, S., Banerjee, S., & Ghosh‐Roy, A. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010885 · Cited by 9 · see citing works

Macroscopic and microscopic diversity of missplicing in the central nervous system of patients with myotonic dystrophy type 1

Furuta, M., Kimura, T., Nakamori, M., Matsumura, T., Fujimura, H., Jinnai, K., Takahashi, M. P., Mochizuki, H., & Yoshikawa, H. (2018) · Neuroreport · doi:10.1097/wnr.0000000000000968 · Cited by 9 · see citing works

RNA structure in alternative splicing regulation: from mechanism to therapy

Bao, N., Wang, Z., Fu, J., Dong, H., & Jin, Y. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024119 · Cited by 9 · see citing works

Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies

Kościańska, E., Kozłowska, E., & Fiszer, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116089 · Cited by 8 · see citing works

An in vivo knockdown strategy reveals multiple functions for circMblPreprint

Pamudurti, N. R., Konakondla-Jacob, V. V., Krishnamoorthy, A., Ashwal-Fluss, R., Bartok, O., Wüst, S., Seitz, K., Maya, R., Lerner, N., Patop, I. L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/483271 · Cited by 7 · see citing works

Increased EEG Theta Spectral Power in Sleep in Myotonic Dystrophy Type 1

Cheung, J., Ruoff, C. M., Moore, H. E., Hagerman, K. A., Perez, J. M., Sakamuri, S., Warby, S. C., Mignot, E. J.-M., Day, J., & Sampson, J. B. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6940 · Cited by 7 · see citing works

Deregulation of RNA Metabolism in Microsatellite Expansion Diseases

Misra, C., Lin, F., & Kalsotra, A. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_8 · Cited by 7 · see citing works

Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2

Spitalieri, P., Talarico, R. V., Murdocca, M., Fontana, L., Marcaurelio, M., Campione, E., Massa, R., Meola, G., Serafino, A., Novelli, G., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00967 · Cited by 7 · see citing works

A Muscleblind Knockout Model for Myotonic Dystrophy

Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743 · see citing works

Molecular Mechanisms of Myotonic Dystrophy: RNA-Mediated Pathogenesis and RNA-Binding Proteins

Kino, Y., Satoh, J., & Ishiura, S. (2018) · Springer eBooks · doi:10.1007/978-981-13-0508-5_2 · Cited by 2 · see citing works

Loss of MBNL Leads to Disruption of Developmentally Regulated Alternative Polyadenylation in RNA-Mediated Disease

Batra, R., Charizanis, K., Manchanda, M., Mohan, A., Li, M., Finn, D. J., Goodwin, M., Zhang, C., Sobczak, K., Thornton, C. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.027 · Cited by 292 · see citing works

Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy

Charizanis, K., Lee, K.-Y., Batra, R., Goodwin, M., Zhang, C., Yuan, Y., Shiue, L., Cline, M., Scotti, M. M., Xia, G., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.029 · Cited by 324 · see citing works

MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity

Yadava, R. S., Kim, Y. K., Mandal, M., Mahadevan, K., Gladman, J. T., Yu, Q. C., & Mahadevan, M. S. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz065 · Cited by 24 · see citing works